# Cross Trails Medical Center

Health Center, MO
Page: https://astrelis.co/providers/health_center/261837  
This twin: https://astrelis.co/providers/health_center/261837.md  
CMS Certification Number (CCN): 261837  
Release: 2321a4fc37a7 (2026-10-22)

## Headline figures (fiscal years on file: 2019 to 2025)

- **Total patients (UDS) (FY2024):** 11,224. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Total visits (all service types) (FY2024):** 36,398. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Service sites (FY2024):** 5. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Uninsured patient share (FY2024):** 7.8%. Illustrative estimate. Definition: https://astrelis.co/methodology#health-center
- **Operating margin (FY2025):** -8.8%. Astrelis calculation. Definition: https://astrelis.co/methodology#health-center
- **Total operating revenue (FY2025):** $15.0M. Reported value. Definition: https://astrelis.co/methodology#health-center
- **Total margin (including nonoperating) (FY2025):** +10.2%. Astrelis calculation. Definition: https://astrelis.co/methodology#health-center

## Audited financial statements (Federal Audit Clearinghouse)

Read from the FAC-11 template of the audited statements: every line, every ratio and every status column print as the template carries them, and no figure is withheld. A report's tie status says whether its statements foot; a ratio's plausibility status says whether it sits inside its possible range; a median of fewer than five values says so. The figures were not audited by Astrelis. Contract: https://astrelis.co/methodology/fqhc-audit-contract

### Cross Trails Medical Center, MO

Match to this profile: matched by name (method: name and state).

- FY ending 2025-12-31 (audit year 2025): ties in full; audit as filed https://app.fac.gov/dissemination/summary/2025-12-GSAFAC-0000415043
- FY ending 2024-12-31 (audit year 2024): ties in full; audit as filed https://app.fac.gov/dissemination/summary/2024-12-GSAFAC-0000366664
- FY ending 2023-12-31 (audit year 2023): ties in full; audit as filed https://app.fac.gov/dissemination/summary/2023-12-GSAFAC-0000041332

| Line | FY ending 2025-12-31 | FY ending 2024-12-31 | FY ending 2023-12-31 |
|---|---:|---:|---:|
| cash and investments (current) (Statement of financial position) | 9,452,936 [derived, p.6] | 5,878,691 [derived, p.6] | 6,598,733 [derived, p.6] |
| patient receivables, net (Statement of financial position) | 2,554,729 [derived, p.6] | 3,361,058 [derived, p.6] | 2,355,526 [derived, p.6] |
| grants and other receivables (Statement of financial position) | 585,110 [derived, p.6] | 620,735 [derived, p.6] | 289,381 [derived, p.6] |
| other current assets (Statement of financial position) | 127,021 [derived, p.6] | 231,959 [derived, p.6] | 170,639 [derived, p.6] |
| TOTAL CURRENT ASSETS (Statement of financial position) | 12,719,796 [extracted, p.6] | 10,092,443 [extracted, p.6] | 9,414,279 [extracted, p.6] |
| property and equipment, net (Statement of financial position) | 7,418,458 [derived, p.6] | 7,939,225 [derived, p.6] | 7,940,000 [derived, p.6] |
| other long-term assets (Statement of financial position) | 362,726 [derived, p.6] | 402,709 [derived, p.6] | 1,813,322 [derived, p.6] |
| TOTAL ASSETS (Statement of financial position) | 20,500,980 [extracted, p.6] | 18,434,377 [extracted, p.6] | 19,167,601 [extracted, p.6] |
| payables and accrued expenses (Statement of financial position) | 1,084,001 [derived, p.7] | 884,827 [derived, p.7] | 803,868 [derived, p.7] |
| deferred revenue (Statement of financial position) | 20,000 [derived, p.7] | absent (not printed, or not read) | absent (not printed, or not read) |
| current debt and leases (Statement of financial position) | absent (not printed, or not read) | absent (not printed, or not read) | 25,349 [derived, p.7] |
| other current liabilities (Statement of financial position) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| TOTAL CURRENT LIABILITIES (Statement of financial position) | 1,104,001 [extracted, p.7] | 884,827 [extracted, p.7] | 829,217 [extracted, p.7] |
| long-term debt and leases (Statement of financial position) | absent (not printed, or not read) | absent (not printed, or not read) | 862,281 [derived, p.7] |
| other long-term liabilities (Statement of financial position) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| TOTAL LIABILITIES (Statement of financial position) | 1,104,001 [extracted, p.7] | 884,827 [extracted, p.7] | 1,691,498 [extracted, p.7] |
| net assets without donor restrictions (Statement of financial position) | 19,396,979 [derived, p.7] | 17,549,550 [derived, p.7] | 17,476,103 [derived, p.7] |
| net assets with donor restrictions (Statement of financial position) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| TOTAL NET ASSETS (Statement of financial position) | 19,396,979 [extracted, p.7] | 17,549,550 [extracted, p.7] | 17,476,103 [extracted, p.7] |
| patient service revenue, net (Statement of activities) | 15,235,574 [derived, p.8] | 11,675,662 [derived, p.8] | 9,522,334 [derived, p.8] |
| pharmacy and 340B revenue (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| federal grants (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| other grants and contracts (Statement of activities) | 2,646,051 [derived, p.8] | 2,681,457 [derived, p.8] | 3,056,126 [derived, p.8] |
| contributions (Statement of activities) | 33,246 [derived, p.8] | 348,361 [derived, p.8] | 121,534 [derived, p.8] |
| other revenue (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| TOTAL REVENUE AND SUPPORT (Statement of activities) | 17,914,871 [extracted, p.8] | 14,705,480 [extracted, p.8] | 12,699,994 [extracted, p.8] |
| salaries and benefits (Statement of activities) | 9,605,857 [derived, p.8] | 8,904,849 [derived, p.8] | 8,060,121 [derived, p.8] |
| supplies and pharmaceuticals (Statement of activities) | 5,770,812 [derived, p.8] | 4,969,187 [derived, p.8] | 3,719,608 [derived, p.8] |
| purchased and professional services (Statement of activities) | 390,913 [derived, p.8] | 388,296 [derived, p.8] | 292,782 [derived, p.8] |
| occupancy (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| depreciation and amortization (Statement of activities) | 568,788 [derived, p.8] | 571,151 [derived, p.8] | 458,297 [derived, p.8] |
| interest (Statement of activities) | 409 [derived, p.8] | 28,788 [derived, p.8] | 56,556 [derived, p.8] |
| other expenses (Statement of activities) | absent (not printed, or not read) | absent (not printed, or not read) | absent (not printed, or not read) |
| TOTAL EXPENSES (Statement of activities) | 16,336,779 [extracted, p.8] | 14,862,271 [extracted, p.8] | 12,587,364 [extracted, p.8] |
| OPERATING RESULT (Statement of activities) | 1,578,092 [extracted, p.8] | -156,791 [extracted, p.8] | 112,630 [extracted, p.8] |
| non-operating and other changes (Statement of activities) | 269,337 [derived, p.8] | 230,238 [derived, p.8] | 401,265 [derived] |
| CHANGE IN NET ASSETS (Statement of activities) | 1,847,429 [extracted, p.8] | 73,447 [extracted, p.9] | 513,895 [extracted, p.9] |
| net assets, beginning (Statement of activities) | 17,549,550 [extracted, p.8] | 17,476,103 [extracted, p.9] | 16,962,208 [extracted, p.9] |
| net assets, end (Statement of activities) | 19,396,979 [extracted, p.8] | 17,549,550 [extracted, p.9] | 17,476,103 [extracted, p.9] |

| Ratio | FY ending 2025-12-31 | FY ending 2024-12-31 | FY ending 2023-12-31 |
|---|---:|---:|---:|
| Days cash on hand | 219 days [plausible] | 151 days [plausible] | 199 days [plausible] |
| Current ratio | 11.52x [plausible] | 11.41x [plausible] | 11.35x [plausible] |
| Operating margin | 8.8% [plausible] | -1.1% [plausible] | 0.9% [plausible] |
| Total margin | 10.3% [plausible] | 0.5% [plausible] | 4.0% [plausible] |
| Patient revenue share | 85.0% [plausible] | 79.4% [plausible] | 75.0% [plausible] |
| Grant dependency | absent [not computed] | absent [not computed] | absent [not computed] |
| Salaries share | 58.8% [plausible] | 59.9% [plausible] | 64.0% [plausible] |
| Days in patient receivables | 61 days [plausible] | 105 days [plausible] | 90 days [plausible] |
| Debt to net assets | absent [not computed] | absent [not computed] | 0.05x [plausible] |
| Health center award share | absent [not computed] | absent [not computed] | absent [not computed] |

## Sources

HRSA Uniform Data System (awardee level; organization match Verified). CMS HCRIS cost reports, form CMS-224-14, as filed (the Medicare cost-report appendix). Federal Audit Clearinghouse single audits as filed (Cross Trails Medical Center; FAC-11 template snapshot, SRC-FAC-001); the organization match is matched by name.

Methodology: https://astrelis.co/methodology · Data sources: https://astrelis.co/data-sources · Data philosophy: https://astrelis.co/data-philosophy

## Cite this page

Astrelis Atlas, "Cross Trails Medical Center", https://astrelis.co/providers/health_center/261837, release 2321a4fc37a7 (2026-10-22). Figures as filed in the named public sources; not audited by Astrelis.

Figures are as filed in the named public sources. Astrelis is not a CPA firm and performs no audit, review or attestation of any facility.